161 related articles for article (PubMed ID: 4716652)
1. [Clinical studies with a new tocolytic agent (Th 1165 a). Contribution to the management of threatening premature labor].
Schmidt J; Hirdes G
Zentralbl Gynakol; 1973 Mar; 95(11):361-9. PubMed ID: 4716652
[No Abstract] [Full Text] [Related]
2. [Effects of suppression of labor with Th 1165 a and Isoptin on the mother, the new-born and infant (author's transl)].
Weidinger H; Wiest W; Dietze S; Witzel K
Z Geburtshilfe Perinatol; 1973 Oct; 177(5):366-72. PubMed ID: 4777494
[No Abstract] [Full Text] [Related]
3. [The influence of a tocolytic therapy with Th 1165 a on the excretion of total oestrogens in urine in the second half of pregnancy (author's transl)].
Jütting G; Austermann R; Barényi W; Biemann-Hochstrate C
Z Geburtshilfe Perinatol; 1973 Oct; 177(5):356-66. PubMed ID: 4777493
[No Abstract] [Full Text] [Related]
4. [The effect of the calcium inhibitors verapamil (Isoptin) und D 600 on the side effects of the inhibition of labour with the beta-adrenergic drug Th 1165 a (Partusisten)].
Neubüser D
Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):782-7. PubMed ID: 4155046
[No Abstract] [Full Text] [Related]
5. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
Bärmig H; Krzoska C
Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
[No Abstract] [Full Text] [Related]
6. [Inhibition of labour by hydroxyphenyl-orcipeualin-aerosol (Th 1165 a, fenoterol) (author's transl)].
Zahn V
Geburtshilfe Frauenheilkd; 1973 Oct; 33(10):818-21. PubMed ID: 4767408
[No Abstract] [Full Text] [Related]
7. [Partusisten in obstetrics].
Zahn V; Johannigmann J
Zentralbl Gynakol; 1975; 97(10):605-11. PubMed ID: 1189750
[TBL] [Abstract][Full Text] [Related]
8. [Aspects of the therapy of threatened premature labor].
Unbehaun V; Conradt A; Meiswinkel E
Med Welt; 1972 Dec; 23(51):1920-2. PubMed ID: 4145263
[No Abstract] [Full Text] [Related]
9. [The treatment of late abortion and of threatened premature birth with Th 1165 a combined with Isoptin (author's transl)].
Weidinger H; Wiest W
Z Geburtshilfe Perinatol; 1973 Aug; 177(4):233-7. PubMed ID: 4149060
[No Abstract] [Full Text] [Related]
10. [Action of orciprenaline as an inhibitor of uterine contractions in threatened premature labor. Secondary effects on the maternal cardiovascular system and on the fetal heart rhythm. Clinical contribution].
Scarpa F; Vucusa C
Minerva Ginecol; 1976 Jan; 28(1):69-86. PubMed ID: 1256708
[No Abstract] [Full Text] [Related]
11. [Treatment of threatened premature labor. Clinical observations with toxicologic drugs].
Vangen O
Tidsskr Nor Laegeforen; 1973 Apr; 93(12):850-2. PubMed ID: 4752586
[No Abstract] [Full Text] [Related]
12. [Simultaneous application of a beta-adrenergic sympathicomimetic and beta-adrenergic antagonist during inhibition of labor (author's transl)].
Müller-Tyl E; Reinold E; Hernuss P
Z Geburtshilfe Perinatol; 1974 Apr; 178(2):128-34. PubMed ID: 4154069
[No Abstract] [Full Text] [Related]
13. [Effects of isoxsuprine in threatened premature labor and in labor (clinical contribution of 158 cases)].
Moggian G; Zulli P; Aquilina M; Tamburini E
Riv Ital Ginecol; 1976; 57(4-6):363-416. PubMed ID: 1052386
[No Abstract] [Full Text] [Related]
14. [Practical use of orciprenaline in obstetric emergencies].
Guzmán Sánchez A; Torres Farías E; Ramírez Esparza C
Ginecol Obstet Mex; 1973 Jul; 34(201):57-65. PubMed ID: 4727875
[No Abstract] [Full Text] [Related]
15. Uterine and cardiovascular effects of ritodrine in premature labor.
Bieniarz J; Motew M; Scommegna A
Obstet Gynecol; 1972 Jul; 40(1):65-73. PubMed ID: 5044938
[No Abstract] [Full Text] [Related]
16. [Prospective study on the problem of short-term tocolytic treatment].
Seifert B; Neef G; Gstöttner H; Röpke F; Woraschk HJ
Zentralbl Gynakol; 1974 Oct; 96(42):1313-8. PubMed ID: 4458346
[No Abstract] [Full Text] [Related]
17. [The use of orciprenaline in labor].
Resta P; Ambrosini A; Polacco V; Tambuscio B
Minerva Ginecol; 1976 Jun; 28(6):479-85. PubMed ID: 1018829
[No Abstract] [Full Text] [Related]
18. [Intrauterine pressure and fetal and maternal heart rate on administration of the betamimetic agent, hexoprenaline during labour (author's transl)].
Bernaschek G; Hondros K; Schaller A
Wien Klin Wochenschr; 1981 Sep; 93(17):541-7. PubMed ID: 7303700
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of premature labor with a new beta-mimetic agent: pre-par Duphar (Ritodrine). Results in 90 cases].
Romanini C; Moneta E; Oliva GC
Ann Ostet Ginecol Med Perinat; 1972 Dec; 93(12):888-904. PubMed ID: 4669292
[No Abstract] [Full Text] [Related]
20. [Clinical results of treatment with orciprenaline of threatened abortion of premature labor. Use of Alupent in obstetrics].
Conte D; Cisotto F
Minerva Ginecol; 1972 Apr; 24(6):309-19. PubMed ID: 4671739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
